Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses

Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses

IntroductionRecent findings reveal that the precursors of exhausted CD8+ T (CD8+ Tpex) cells possess stem-like signatures in tumor immunity, which originate from tumor draining lymph node (TdLN)-derived tumor-specific memory (CD8+ TTSM) cells. Both of these T subsets can be collectively referred to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaokang Ruan, Linwei Wu, Zijian Tang, Yao Li, Jin Wang, Haolin Jiang, Li Zhang, Shengjia Wang, Zhaoqiang Chen, Chenlei Yuan, Yujian Xia, Yan Pan, Jianling Gao, Xin Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Immunology
Subjects:	chemotherapeutic agents CD62L+ CD8+ Tpex cells CD8+ TTSM cells Eomes antitumor immune responses
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533857/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic exploration of the molecular characteristics of CD8+ T cells to predict the response to immunotherapy and the prognosis of patients with colon adenocarcinoma
by: Xin Shen, et al.
Published: (2024-12-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19
by: D. Torres-Gonzales, et al.
Published: (2025-07-01)

CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
by: Rongpu Liang, et al.
Published: (2025-02-01)

Association of Absolute Lymphocyte Count and Circulating CD4+ and CD8+ T-Cells with Positive Clinical Outcome in Survivors of Cancer: An Observational Study
by: Suresh Rao, et al.
Published: (2019-07-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

Research of subpopulation CD3+ CD4- CD8- double-negative T lymphocytes in kidney transplant recipients
by: S. V. Zybleva, et al.
Published: (2020-03-01)

COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China
by: Yanyan Li, et al.
Published: (2024-12-01)

Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study
by: Jiaye Liu, et al.
Published: (2020-01-01)

Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells
by: Susan N Christo, et al.
Published: (2024-01-01)

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma
by: Jiang Y. Zhao, et al.
Published: (2025-01-01)

Effects of Anti-GPIbαantibody on the expression of platelet GPIbα,CD62P and CD63 in maintenance hemodialysis patients
by: LUO Min-hong, et al.
Published: (2018-01-01)

Tapak liman (Elephantopus scaber L) Extract Induced CD4+ and CD8+ Differentiation from Hematopoietic Stem Cell/Progenitor Cell Proliferation of Mice (Mus musculus)
by: M. Sasmito Djati, et al.
Published: (2015-12-01)

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines
by: Cynthia González Muñoz, et al.
Published: (2025-05-01)

Gzmk+ CD8 T cells in inflammatory diseases
by: Cui Xin, et al.
Published: (2025-08-01)

Intrahepatic CD161hiCD8+T Cell Recruitment Has a Pathogenetic Potential in Chronic HBV Infection
by: Jianfei Li, et al.
Published: (2025-01-01)

CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy
by: Coralie Schoumacher, et al.
Published: (2024-12-01)

Dynamics of subpopulations of CD15<sup>+</sup>CD66b<sup>+</sup> and CD62L<sup>+</sup>CD63<sup>+</sup> circulating neutrophils in patients with benign neoplasms and progression of kidney cancer
by: I. R. Myagdieva, et al.
Published: (2025-06-01)

Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIV
by: Matteo Vassallo, et al.
Published: (2025-04-01)

The Potential of EMSA Eritin to Modulate T Cells (CD4+ and CD8+) in Balb/C Mice Model of Diabetes Mellitus
by: Ade MC Rohie, et al.
Published: (2015-06-01)

CD4/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: a retrospective study
by: Thibaut Zannese, et al.
Published: (2025-05-01)

Expression and significance of platelet GPIb alpha,CD62P and CD63 in maintenance haemodialysis patients
by: LUO Min-hong, et al.
Published: (2018-01-01)

CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation
by: Serena Spampinato, et al.
Published: (2025-06-01)

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype
by: Jingjing Qu, et al.
Published: (2025-07-01)

CD4+T and CD8+T cells profile in lung inflammation and fibrosis: targets and potential therapeutic drugs
by: Xiaobo Sun, et al.
Published: (2025-05-01)

CD73+CD8+ T cells define a subset with anti-tumor potential in DLBCL patients
by: Lingyu Zhang, et al.
Published: (2025-05-01)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
by: Jingjing Qu, et al.
Published: (2024-12-01)

Exosomes: Key Messengers Mediating the Interaction Between Tumor Cells and CD8+ T Cells in the Tumor Microenvironment
by: Li Y, et al.
Published: (2025-01-01)

肝星状细胞通过诱导产生CD8+CD28-T淋巴细胞抑制T细胞增殖
Published: (2016-01-01)

Effects of fermented Crescentia cujete L. on the profile of haematology, clinical chemistry and circulatory CD4+/CD8+ in Sprague Dawley rats
by: Agustina Dwi Wijayanti, et al.
Published: (2024-09-01)

CD36 promotes iron accumulation and dysfunction in CD8 T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma
by: Yifei Qin, et al.
Published: (2025-07-01)

Predictive value of pretreatment peripheral blood N/CD4 and N/CD8 ratios for the efficacy of radiotherapy for esophageal cancer
by: Jiang Yu-Rong, et al.
Published: (2025-03-01)

Intratumoral CD8+ tumor-infiltrating lymphocytes as prognostic predictors in radio-chemoradiotherapy-treated nasopharyngeal carcinoma
by: Xinjing Li, et al.
Published: (2025-05-01)

A Study to Delineate the Immunohistological Parameters of Active Versus Stable Vitiligo Using S100, Melan A in Conjunction with CD4 and CD8 Immunohistochemistry Markers
by: Sai Jyoti, et al.
Published: (2025-07-01)

Global research trends in the relationship between influenza and CD4+ T/CD8+ T cells: A bibliometric analysis
by: Yanping Zong, et al.
Published: (2024-12-01)

Immunohistochemical analysis of PD-L1, CD4, CD8, CD20, and PU.1 expression in a dedifferentiated chondrosarcoma: the clinical and prognostic value
by: Olga V. Kovaleva, et al.
Published: (2025-07-01)

The CD4/CD8 ratio is associated with T lymphocyte functions in long-term virally suppressed patients with HIV
by: Qing Xiao, et al.
Published: (2025-01-01)

IL-6 and CD4+/CD8+ are Important Indicators for Predicting Prognosis in Elderly AECOPD Patients: A Retrospective Study
by: Liu Q, et al.
Published: (2025-02-01)

Development and validation of a CD4+/CD8+ ratio-based nomogram to predict plastic bronchitis in pediatric Mycoplasma pneumoniae pneumonia
by: Di Lian, et al.
Published: (2025-07-01)

Decoupled dynamics of absolute and relative lymphocyte counts and age−polarized CD4+/CD8+ ratio in infants versus older adults
by: Ting Ge, et al.
Published: (2025-07-01)